CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.
The Centers for Medicare & Medicaid Services (CMS) recently orchestrated a $5 billion election-year rescue operation for Democrats to hide the true costs of the Biden-Harris administration's Inflation ...
The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for enrollees in Medicare Part D and Medicaid plans, but experts say it's unclear how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results